It is not well establishedwhether haemorheological alterations constitute independent riskf actors ford eep vein thrombosis (DVT).We have determinedin149 DVTpatientsand in 185 control subjects the bodymass index(BMI), the haemorheological profile: blood viscosity (BV), plasma viscosity (PV), fibrinogen (Fg),e rythrocyte aggregation (EA), erythrocyte deformability (ED)and plasma lipids.Inthe crudeanalysis BMI, Fg,PV, EA, triglycerides (TG)and ApoB were statisticallyhigher and HDLcholesterol (HDL-Chol) statisticallylower in DVTpatientsthan in controls. No differencesinBVand ED were observed.After BMI adjustment, Fg, PV and EA remaineds tatisticallyh igher in DVT cases than in controls (P=0.013; P=0.012; P=0.013; P=0.028, respectively).Whent he risk of DVTa ssociated with these vari-
Introduction
Deep vein thrombosis (DVT) is amultifactorialdiseaseinwhich inherited and acquiredrisk factorsplayanimportant pathogenic role (1) . Since Virchow, it is assumedthat blood flowalterations (haemorheological alterations) mayf avour the development of venous thrombus (2) .T he rheologicalh ypothesis for venous thrombogenesis is supported by the association of manyrisk factorsfor DVTwith systemic rheological alterations (3, 4) and the association of some rheologicalvariableswith DVTincase-control studies (5) (6) (7) (8) (9) (10) . However, there is not enoughe videncet o prove thathaemorheological alterationsconstitute independent risk factorsfor DVTwhen patients areevaluatedout of the acute phase,w hen the temporary fibrinogen increase (the protein whichm odulates most of the haemorheologicalp arameters)i s stronglym arked. Moreover, studiesc onducteds of ar consist mainlyofasmall sample size (6, 7, 9, 11, 12) , do not determine allthe rheologicalparameters (5) (6) (7) (8) 10) , do not excludepatients with malignant, inflammatory, autoimmune or infectious diseases (11, 12) that entail markedfibrinogenincreases and,inaddition, theydonot always considerthe presenceofconcomitant classical cardiovascularr isk factors, i.e.o besity,h ypertension, diabetes, dyslipidaemia and tobacco (6-9, 11, 12) , whichcan not be overlookedastheyaffect rheological blood behaviour,acting as confounders. In particular, both obesity (13) (14) (15) (16) (17) (18) and hyperlipidaemia (16,1 9-26) appear to be associated with at wo-t o four-foldincreased risk of DVT. The prothrombotic pathogenic mechanisms of obesity, as well as hyperlipidemia, arenot clearly established. One possible mechanismcould be by modifying the blood flowc haracteristics, givent hat lipids and fibrinogen, whicha re increased in both conditions,m ay modulate most of the haemorheological parameters.
The aim of the present study wastoassess the overallhaemorheological profile six to 12 monthsafter the acuteepisode in patients with DVT, i.e.b lood viscosity (BV), plasmav iscosity (PV) and erythrocyte aggregation (EA) and deformability (ED), to find out whether some haemorheological parameters constitute independent risk factorsfor DVTand to determine whether the lipid alterationst hemselves or those due to obesity could modify rheologicalparameters and thus promote DVT.
Materials andmethods

Study group
One hundred and forty-nine patients withp reviouslyd ocumented DVT(86 male, 63 female) aged42±12 years were referred to our Haemorheology and Thrombosis Unit between January2003 and October 2006. Theyall hadexperienced afirst DVTe pisode six to 12 months before sampling (mean, 9±3 months).Exclusion criteria were: organic, malignant, infectious, autoimmune or inflammatoryd iseases,i .e. those pathologies that could influencerheologicalprofile,aswellastreatment with rheological drugs. Those patients with inherited(antithrombin, protein Corprotein Sdeficiency, factor VLeiden,prothrombin G20210A mutation) or acquired (lupus anticoagulant or anticardiolipin antibodies) thrombophilic risk factorsw ere also excluded as their thromboembolic episodescould be explained by haemostatic abnormalities.
The control group wasmade up of 185subjects (aged 42 ±13 years,89male, 96 female) undergoing aroutine check up at our hospital, without ap revioush istoryo fD VT confirmed witha validatedq uestionnaire (27) .C ardiovascularr isk factorsw ere recorded and consideredfor both groups. These included obesity (body mass index[ BMI]> 30 kg/m 2 ), current tobacco use( >1 cigarette/day), hypertension (diastolic blood pressure >90 mmHg), hyperlipidaemia (total cholesterol >220 mg/dl and/or triglycerides>175 mg/dl), fasting glucose >126 mg/dl,orw ere receiving anyp harmacologicalt reatment for hypertension, hyperlipidaemia, or diabetes. Subjects gave their informedconsent to participate in the study,which wasapprovedbythe Hospital Ethics Committee.
Circumstantial patient thrombotic risk factors, i.e.m edical (oral contraceptives,v aricosev eins,p regnancy, bed rest >1 week, heartf ailure, chronic obstructive pulmonaryd isease, obesity,etc), surgery, immobilization, and traumawere recorded (secondaryD VT), and thoset hrombotic eventst hat occurred withouta ny circumstantialr isk factor were considered spontaneous DVT. From the 149 DVTpatients, 111 showedsome circumstantial risk factors(75%) and 38 did not (25%). In the 111 DVTpatients, the percentages of circumstantialrisk factorswere as follows:m edical 41.7%, surgical 17.5%, immobilisation 20.5% and trauma2 0.3%. In addition, 16 of the 149 DVTp atients hadap ulmonarye mbolism( PE). DVTw as documented with ultrasonographyo rv enography, and PE withv entilation perfusion scanning, pulmonary angiography, or helicoidalcomputerised tomography.
Bloodcollection
Bloodw as collected at leasts ix monthsa fter the acutee vent (range 6-12 months;mean: 9±3months). After a12-hour overnight fast, blood wasdrawn between 8and 10 a.m. by venipuncture into standard vacuumtubes containing EDTAK 3 for rheological and haematological measurements, 0.1 volo f0 .129 M trisodium citratea sa na nticoagulant for fibrinogen measurement, or into plain tubesf or glucose and lipids determination. Rheological parameters were examinedwithin 2hours of blood collection, to avoid deterioration of the rheologicalred blood cell properties(28).
Laboratorymethods
Bloodviscosity (BV) wasdeterminedinaBrookfield DVIII viscosimeter( Engineering, Stougthon MA,U SA)a tn ativea nd 45% correctedhematocrit with autologous plasma, at twoshear rates of 230s -1 and 23 s -1 ,a t3 7ºC. Plasma viscosity (PV) was measured in acapillary plasma viscosimeter (Fresenius GmbH, Germany) at 37ºC (29) .Erythrocyte aggregation (EA) wasdeterminedi naM yrenne MA 1 aggregometer( Myrenne, GmbH, Roetgen, Germany) (30) after adjustingthe haematocrit to 45% with autologous plasma, during completeds tasis (EA 0 )a nd while the sample wassubjected to alow shear rateof3s -1 (EA 1 ). Theg reater the tendencyo fr ed blood cell to aggregate,t he higher the aggregability index. Erythrocyte deformability(ED) wasdeterminedinaRheodyn shearstressdiffractometer(Myrenne GmbH)at12, 30 and 60 Pascals (31) . The higher the erythrocyte elongation index( EEI), the more deformable the red blood cell is. Fibrinogen (Fg) wasmeasured using coagulometric techniquesonanACL7000autoanalyser(Instrumentation Laboratory, Milan, Italy). Haematocritwas measured by microcentrifugation at 15,000 xgfor 10 minutes.
Totalcholesterol (T-Chol), low-density lipoprotein-cholesterol (LDL-Chol), high-densityl ipoprotein-cholesterol (HDLChol),t riglycerides,a nd glucose were measured by enzymatic techniques, usingaD AX 72 autoanalyser (BayerD iagnostics Division, Tarrytown, NY,USA). ApolipoproteinsAIand Bwere quantifiedb yi mmunonephelometry( Dade Behring,M arburg GmbH, Germany).
Basic haematological parameters and red celli ndices, including meancellv olume (MCV), meanhaemoglobin concentration (MHC),a nd meanc orpuscularh aemoglobin concentration (MCHC), were measured in aSysmexME8.000 autoanalyser(TOAMedical Electronics,Kobe, Japan).
BV wasdeterminedinarandom sample of 102 cases and 105 controls and ED in 40 cases and 59 controls. Casesand controls were well matchedfor age and sex. Patients and controls samples were processed simultaneously.
Statisticalanalysis
All continuousv ariablesw ere checked fornormal distribution. TG, glucose and Fg valuesw ere log-transformed forstatistical testing.The data areexpressed as mean±one standard deviation (SD). Student'st-test wasusedtoassess the meandifferences in continuous variablesbetween patients and control subjects, and Chi 2 -testsw ere used to comparedifferences in percentages between patients and controls. Pearson correlation coefficients were calculatedtodescribe the bivariate correlation amongvari-ables. Multiple linealr egression analysis (covariance method) wasusedtoadjust for the influenceofBMI or the otherparameters on the unadjustedd ifferences of means in lipids,f ibrinogen, plasma viscosity and erythrocytea ggregation between DVTpatients and controls. In these analyses,weuseddifferent models dependingo nt he adjusted variable.F irst, we adjusted each variable thatwas statistically significant in the crudemodel for all the other variablesthat were statistically significant in the unadjustedanalysis. Taking into account that after these adjustment BMI wast he onlyv ariable thatr emained highly significant,wefittedadditional multivariate models in whicheach lipid and haemorheological parameters were only adjustedfor BMI. Logistic regression models (crude and adjusted for potential confounders) were fittedt oe stimate the odds ratio (OR) and 95%confidenceinterval(CI)ofD VT associated withthe presenceofobesity and/or the other haemorheologicalparameters.In these analyses,d ichotomisedv ariablesa ccording to cut-off points that corresponded to the meanplus one SD of the control group were used. Standard regression diagnostic procedures were used to ensurethe appropriateness of the models.
Fors tatistical inference, ab ilateral p-value< 0.05 wasc onsidereds tatistically significant. All analyses were calculated using the StatisticalPackagefor Social Sciences (SPSS,version 14) for Windows.
Results
Table1shows the percentage of DVTpatients and controls with cardiovascularrisk factors. DVTpatients showedahigherpercentage of hyperlipidaemia (46% vs. 35%, P=0.040) and obesity (23% vs. 6%, P=0.001) than controls. Whenhypercholesterolemia (T-Chol> 220 mg/dl)a nd hypertriglyceridemia (TG >175 mg/dl)were consideredseparately, DVTpatients showeda borderline increased percentage of hypercholesterolemia (P=0.040) and ah igherp ercentage of hypertriglyceridemia (P=0.001). The percentage of hypertensives, diabetics and smokers wassimilarinD VT patients and control subjects.
Table2s hows BMI, glucose,l ipids and haemorheological parameters in the 149 DVTp atients and 185c ontrol subjects. OnlyBMI, TG,Apo B, B/AIratio, Fg, PV,EA 0 and EA 1 were significantly higher and HDL-Chol lowerincases thanincontrols. After multivariate adjustment for the potentialconfounding factors, onlyBMI remainedsignificantly different (P<0.001). After adjusting for BMI, onlyFg, PV,EA 0 and EA 1 remained significantly different betweenpatients and controls.
No statistical differences in rheological parameters were observed between patients with spontaneous and secondaryDVT.
No differences in erythrocyteindiceswere observed between patients and controls (MCV: 91 ±1 0v s. 90 ±5fl,P =0 . Giventhe multiple correlations betweenthe rheologicalparameters,lipids and BMI,toestimate the risk of obesity associated with these parameters, al ogistic regression analysis was carried out. Instead of continuous variables, dichotomized variables(according to cut-off points that corresponded to the mean plus one SD of the control group) were used for the analysed parameters to betterestimate the risk associatedwith high values. Crude and multivariate models were estimatedfor each variable. Table3shows OR of DVTassociatedwith haemorheological parameters (EA 1 >8.2, PV>1.28 mPa . s, Fg>320 mg/dl) and obesity (BMI>30 kg/m 2 ). In the crudeModel Iall parameters were significantly associatedwith ahigherrisk of DVT. This association remained statisticallysignificant even further adjustment for lipids (ModelII) and BMI (Model III). When PV wasadditionally adjustedfor Fg (ModelIV) this parameter didnot remained statisticallysignificant.However,EA 1 ,BMI and Fg remained statistically significant in ModelIV.
Moreover, when we consideredtogether allthe analysedvariablesinorder to control everyvariable for each other and to know whether theyconstitute independent risk factorsfor DVT, we obtained that TG >175 mg/dl (OR=3.2, 95% CI=1.4-7.3, P = 0.004), Fg>320 mg/dl (OR=2.7, 95% CI=1.3-5.6, P=0.008), EA 1 >8.2 (OR=2.8, 95% CI=1.3-5.9, P=0.007) and BMI >30 kg/m 2 (OR=3.5, 95%CI=1.5-8.1, P=0.003),but not PV >1.28 mPa . snor T-Chol>220 mg/dl remained significantly associated withD VT.Therefore TG, Fg, EA 1 and BMI constitute independent risk factorsfor DVTw hen theyreach high values(higher than meanplus one SD).
Discussion
The results obtained in the present study indicate that DVTpatients do not showahigherBVcompared to the control group, *T-Chol>220mg/dland/or TG>175 ml/dl or were receiving anypharmacologicaltreatment. ** T-Chol>220 mg/dl or were receiving anypharmacologicaltreatment. *** TG>175 ml/dl or were receiving anypharmacologicaltreatment.
both at native and 45%correctedhaematocrit. Little information is availableo nD VT case-control studies regarding BV evaluation. Ourresults agree with thosepreviouslyreported (5,6,9, 11, 12) in not having found differencesbetween both groups. It is well known thatBV, when determinedathigh shear rate, is aglobalr heologicalp arameter,d epending on haematocrit, Fg concentration and ED.Given thatDVT patients in thepresentstudy did not showalower ED either, it is reasonable that, at the shear rates used (230 s -1 and 23 s -1 )whereBVbasically depends on ED, the formerdid not showany significant differencewith respect to the control group. The significant increase in Fg observedin cases compared with controls doesnot seemtobehigh enoughto producesignificant increases in BV.Our resultsagree with several studiesw hereD VT patients show significant Fg increases even three monthsormore after the acute event (5, 6, (8) (9) (10) (11) (12) . In line with these results, in the population-basedcasecontrol study 1.09-3.37
1.66-6.67
-----conducted by Koster (8) , in which199 patients with afirst DVT episode were compared with 199 healthys ubjects, those with plasma Fg higher than 500 mg/dl had an almost four-fold increased risk of DVT. With respect to ED,asmentioned, we did not observe differences between cases and controls at anyo ft he shears tresses tested. There have beennostudiespublished,sofar,wherethis rheologicalparameter has been evaluatedusing ektacytometric techniques, as in the present one. Previous studies (32, 33) that found controversialresults regarding ED in DVTpatients, used older filtration methodsthat maybeinfluencedbyextra-erythrocytic factorssuch as remnant leucocytes, redb lood cellaggregateso rp lasma factors ( 34, 35) , whereas ektacytometry does not.
As regards the otherrheologicalparameters analysed in the present study,itisimportant to highlight thatDVT patients have shown increased PV and EA when compared with controls. It is known thatboth rheologicalparameters are influenced by plasma lipids (10, (36) (37) (38) (39) and Fg levels (40) (41) (42) , whichh avea lso shown to be increased in our study. Additionally,obesity is also associated with increased Fg and TG levels (14, 16, 21, (43) (44) (45) (46) . In the present study,t he risk associated with obesity (BMI ≥ 30 kg/m 2 )was 3.5(95% CI 1.5-8.1), whichisinline with previousstudiescarried outbyour group where the risk of DVTassociatedwith obesity was2.5 (95% CI 1.2-5.1) (16) .For this reason, the first question we should consideris: Is the increasein these rheological parameters,PVand EA, due to an independent increase in Fg and lipids or is their increase associated to obesity? In other words,ifpatients with DVTwere notobese:Would theys till have increased PV and EA?O ur logistic regression models (Table 3) indicatethat EA 1 >8.2 and PV >1.28 mPa . s were significantly associatedwith DVTevenfurther adjustment for lipids (ModelII) and obesity (Model III). These results suggest that PV and EA areincreased in DVTpatients independently of lipidlevelsand the obesity status. However, PV didnot remain statisticallys ignificant after additionala djustment for Fg (ModelI V), givent he high influenceo fFgonthis rheological parameter.Therefore,inDVT patients EA 1 >8.2 constitutes arisk factor forD VT,increasing the risk even though patients would not be obese.However,the fact of being obesewould further increase the risk.
Several authors have also found EA to be increased in DVT patients 12 months after the acute event (6,1 0-12). Somer esearchers have found higher EA only in thosepatients with persistent thrombotic risk factorsb ut not in those with transient thromboticrisk factors (11) . In this sense,wehavenot observed anydifferences in this rheological parameter in connection with the natureofthe thromboticepisode, i.e. spontaneous or secondaryD VT.I tm ust be emphasised that some studies include patients with malignancy (11, 12) where increased Fg could have beenr esponsible for erythrocyte hyperaggregability.O thera uthors (7) performed the study six weeks after the acuteepisode, where the acutephase could have influenced results and,inaddition, most studies did not measure plasma lipids whichmay also account forerythrocyte hyperaggregability.Inour study,the influence of acute phase or malignancyhas been excluded,and the role playedbylipids on EA hasalso been evaluated, allowingus to concludet hat, according to our logistic regression analysis, EA 1 >8.2 is an independent thromboticrisk factor,increasing the risk almost threetimes.
As regards PV in DVTpatients, onlysome studies did determine this rheological parameter,findingittobenormal (9, 10) or increased (5, 6) in association with higher cholesterol and TG levels (5). Moreover, Balendra et al. (5) reported PV to be an independent risk factor forD VT.Although the present study has found PV to be increased in DVTpatients and associatedwith lipids and mostlywith Fg levels, it doesnot constituteanindependent risk factor forD VT (Model IV). Thisisconsistent with the pathophysiologyo ft he different thromboticl ocations,a si ncreases in PV mostly promote thrombus development in the microcirculatory areas and small arteries, whereas increases in EA promote thrombus formation in low-shear areas sucha s pocket valves in the lowerextremities.
In conclusion, the resultsobtained in the present study,performedi nal arge group of patients with aD VT episode in the previous 6-12 months,allowustoconclude that rheologicalparameters play arole in the pathogenesis of the thromboticevent. IncreasedEAconstitute arisk factor forD VT independently of lipidl evelsa nd obesity status. However, when associatedw ith hyperlipidaemia and obesity it further increases thromboticrisk. It is reasonable to advise losingw eightand to decrease plasma lipidlevelsinorder to reduce DVTrisk.
